DelSiTech Ltd is thrilled to announce a global license and development agreement with Tolmar, marking a significant milestone in our partnership since their investment in January 2024. Under the terms of the agreement, #Tolmar will obtain a global license to utilize #DelSiTech’s proprietary Silica Matrix technology for two undisclosed drug targets. In addition, both companies will collaborate to expand the development of additional drug products across a range of therapeutic areas. This #collaboration further strengthens our partnership with Tolmar and holds immense promise for innovative #DrugDelivery solutions. We look forward to sharing more updates in the future. Read more about the collaboration here: https://bit.ly/4bE2ayg #DelSiTech #drugdevelopment #SilicaMatrix
Congratulations DelSiTech team!
Senior Director for Clinical Business Development
8moWow! Congrats DelSiTech Ltd and Tolmar ! Exciting and a great start to 2024 and the world of #ophthalmology !!